Global Rescue of Defects in HIV-1 Envelope Glycoprotein Incorporation: Implications for Matrix Structure

PLoS Pathogens

Volumn 9, Issue 11, 2013, Pages

  Tedbury, Philip R ^a   Ablan, Sherimay D ^a   Freed, Eric O ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; VIRION; VIRUS ASSEMBLY; VIRUS INFECTIVITY; VIRUS RELEASE; VIRUS REPLICATION;

GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HELA CELLS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; JURKAT CELLS; MUTATION;

EID: 84888211714     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003739     Document Type: Article

References (70)

1. Sundquist WI, Kräusslich H-G, (2012) HIV-1 Assembly, Budding, and Maturation. Cold Spring Harbor perspectives in medicine 2: a006924 doi:10.1101/cshperspect.a006924.
2. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO, (2004) Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proceedings of the National Academy of Sciences of the United States of America 101: 14889-14894.
3. Waheed AA, Freed EO, (2010) The role of lipids in retrovirus replication. Viruses 2: 1146-1180 doi:10.3390/v2051146.
4. Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, et al. (2004) Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proceedings of the National Academy of Sciences of the United States of America 101: 517-522 doi:10.1073/pnas.0305665101.
5. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, et al. (2006) Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proceedings of the National Academy of Sciences of the United States of America 103: 11364-11369 doi:10.1073/pnas.0602818103.
6. Checkley MA, Luttge BG, Freed EO, (2011) HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. Journal of molecular biology 410: 582-608 doi:10.1016/j.jmb.2011.04.042.
7. Johnson MC, (2011) Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS research and human retroviruses 27: 239-247 doi:10.1089/AID.2010.0350.
8. Postler TS, Desrosiers RC, (2012) The Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41. Journal of virology doi:10.1128/JVI.02053-12.
9. Murakami T, Freed EO, (2000) The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proceedings of the National Academy of Sciences of the United States of America 97: 343-348.
10. Murakami T, Freed EO, (2000) Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. Journal of virology 74: 3548-3554.
11. Qi M, Williams JA, Chu H, Chen X, Wang J-J, et al. (2013) Rab11-FIP1C and Rab14 Direct Plasma Membrane Sorting and Particle Incorporation of the HIV-1 Envelope Glycoprotein Complex. PLoS Pathogens 9: e1003278 doi:10.1371/journal.ppat.1003278.
12. Postler TS, Desrosiers RC, (2012) The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1. Cell host & microbe 11: 181-193 doi:10.1016/j.chom.2011.12.005.
13. Freed EO, Martin MA, (1995) Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. Journal of virology 69: 1984-1989.
14. Freed EO, Martin MA, (1996) Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. Journal of virology 70: 341-351.
15. Brandano L, Stevenson M, (2011) A Highly Conserved Residue in the C-Terminal Helix of HIV-1 Matrix is Required for Envelope Incorporation into Virus Particles. Journal of virology doi:10.1128/JVI.06047-11.
16. Mammano F, Kondo E, Sodroski J, Bukovsky A, Göttlinger HG, (1995) Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. Journal of virology 69: 3824-3830.
17. Göttlinger HG, Sodroski JG, Haseltine WA, (1989) Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America 86: 5781-5785.
18. Bryant M, Ratner L, (1990) Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proceedings of the National Academy of Sciences of the United States of America 87: 523-527.
19. Freed EO, Orenstein JM, Buckler-White AJ, Martin MA, (1994) Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. Journal of virology 68: 5311-5320.
20. Ono A, Huang M, Freed EO, (1997) Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. Journal of virology 71: 4409-4418.
21. Ono A, Freed EO, (1999) Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. Journal of virology 73: 4136-4144.
22. Saad JS, Loeliger E, Luncsford P, Liriano M, Tai J, et al. (2007) Point mutations in the HIV-1 matrix protein turn off the myristyl switch. Journal of molecular biology 366: 574-585 doi:10.1016/j.jmb.2006.11.068.
23. Ono A, Freed EO, (2004) Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. Journal of virology 78: 1552-1563.
24. Chukkapalli V, Ono A, (2011) Molecular determinants that regulate plasma membrane association of HIV-1 Gag. Journal of molecular biology 410: 512-524 doi:10.1016/j.jmb.2011.04.015.
25. Reil H, Bukovsky AA, Gelderblom HR, Göttlinger HG, (1998) Efficient HIV-1 replication can occur in the absence of the viral matrix protein. The EMBO journal 17: 2699-2708 doi:10.1093/emboj/17.9.2699.
26. Kiernan RE, Ono A, Englund G, Freed EO, (1998) Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. Journal of virology 72: 4116-4126.
27. Kiernan RE, Ono A, Freed EO, (1999) Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity. Journal of virology 73: 4728-4737.
28. Steckbeck JD, Sun C, Sturgeon TJ, Montelaro RC, (2010) Topology of the C-terminal tail of HIV-1 gp41: differential exposure of the Kennedy epitope on cell and viral membranes. PloS one 5: e15261 doi:10.1371/journal.pone.0015261.
29. Steckbeck JD, Sun C, Sturgeon TJ, Montelaro RC, (2013) Detailed topology mapping reveals substantial exposure of the "cytoplasmic" C-terminal tail (CTT) sequences in HIV-1 Env proteins at the cell surface. PloS one 8: e65220 doi:10.1371/journal.pone.0065220.
30. Postler TS, Martinez-Navio JM, Yuste E, Desrosiers RC, (2012) Evidence Against Extracellular Exposure of a Highly Immunogenic Region in the C-Terminal Domain of the SIVmac gp41 Transmembrane Protein. Journal of virology 86: 1145-1157 doi:10.1128/JVI.06463-11.
31. Steckbeck JD, Kuhlmann A-S, Montelaro RC, (2013) C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic. The Journal of general virology 94: 1-19 doi:10.1099/vir.0.046508-0.
32. Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI, (1996) Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proceedings of the National Academy of Sciences of the United States of America 93: 3099-3104.
33. Massiah MA, Starich MR, Paschall C, Summers, Christensen Michael F, Allyson M, Sundquist WI, (1994) Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. Journal of molecular biology 244: 198-223.
34. Rao Z, Belyaev AS, Fry E, Roy P, Jones IM, et al. (1995) Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378: 743-747 doi:10.1038/378743a0.
35. Alfadhli A, Barklis RL, Barklis E, (2009) HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 387: 466-472 doi:10.1016/j.virol.2009.02.048.
36. Massiah MA, Worthylake D, Christensen AM, Sundquist WI, Hill CP, et al. (1996) Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly. Protein science: a publication of the Protein Society 5: 2391-2398 doi:10.1002/pro.5560051202.
37. Cosson P, (1996) Direct interaction between the envelope and matrix proteins of HIV-1. The EMBO journal 15: 5783-5788.
38. Vincent MJ, Melsen LR, Martin AS, Compans RW, (1999) Intracellular Interaction of Simian Immunodeficiency Virus Gag and Env Proteins. Journal of virology 73: 8138-8144.
39. Manrique JM, Affranchino JL, González SA, (2008) In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein. Virology 374: 273-279 doi:10.1016/j.virol.2008.01.015.
40. Joshi A, Ablan SD, Soheilian F, Nagashima K, Freed EO, (2009) Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment. Journal of virology 83: 5375-5387 doi:10.1128/JVI.00109-09.
41. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, et al. (2002) Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy. Antimicrobial Agents and Chemotherapy 46: 1896-1905 doi:10.1128/AAC.46.6.1896-1905.2002.
42. Vinogradov SN, (1979) Hydrogen bonds in crystal structures of amino acids, peptides and related molecules. International Journal of Peptide and Protein Research 14: 281-289 doi:10.1111/j.1399-3011.1979.tb01934.x.
43. Wyma DJ, Kotov A, Aiken C, (2000) Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. Journal of virology 74: 9381-9387.
44. Deschambeault J, Lalonde JP, Cervantes-Acosta G, Lodge R, Cohen EA, et al. (1999) Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission. Journal of virology 73: 5010-5017.
45. Lodge R, Göttlinger H, Gabuzda D, Cohen EA, Lemay G, (1994) The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. Journal of virology 68: 4857-4861.
46. Chojnacki J, Staudt T, Glass B, Bingen P, Engelhardt J, et al. (2012) Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. Science (New York, NY) 338: 524-528 doi:10.1126/science.1226359.
47. Wyma DJ, Jiang J, Shi J, Zhou J, Lineberger JE, et al. (2004) Coupling of Human Immunodeficiency Virus Type 1 Fusion to Virion Maturation: a Novel Role of the gp41 Cytoplasmic Tail. Journal of Virology 78: 3429-3435 doi:10.1128/JVI.78.7.3429-3435.2004.
48. Murakami T, Ablan S, Freed E, Tanaka Y, (2004) Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. Journal of virology 78: 1026-1031 doi:10.1128/JVI.78.2.1026.
49. Wright ER, Schooler JB, Ding HJ, Kieffer C, Fillmore C, et al. (2007) Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. The EMBO journal 26: 2218-2226 doi:10.1038/sj.emboj.7601664.
50. Morikawa Y, Zhang WH, Hockley DJ, Nermut MV, Jones IM, (1998) Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. Journal of virology 72: 7659-7663.
51. Alfadhli A, Huseby D, Kapit E, Colman D, Barklis E, (2007) Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. Journal of virology 81: 1472-1478 doi:10.1128/JVI.02122-06.
52. Yang P, Ai L-S, Huang S-C, Li H-F, Chan W-E, et al. (2010) The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinants. Journal of virology 84: 59-75 doi:10.1128/JVI.00899-09.
53. Lindwasser OW, Resh MD, (2001) Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. Journal of virology 75: 7913-7924.
54. Nguyen DH, Hildreth JE, (2000) Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. Journal of virology 74: 3264-3272.
55. Ono A, Freed EO, (2001) Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proceedings of the National Academy of Sciences of the United States of America 98: 13925-13930 doi:10.1073/pnas.241320298.
56. Hogue IB, Grover JR, Soheilian F, Nagashima K, Ono A, (2011) Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. Journal of virology 85: 9749-9766 doi:10.1128/JVI.00743-11.
57. Krementsov DN, Rassam P, Margeat E, Roy NH, Schneider-Schaulies J, et al. (2010) HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components. Traffic (Copenhagen, Denmark) 11: 1401-1414.
58. Dick RA, Goh SL, Feigenson GW, Vogt VM, (2012) HIV-1 Gag protein can sense the cholesterol and acyl chain environment in model membranes. Proceedings of the National Academy of Sciences of the United States of America 109: 18761-18766 doi:10.1073/pnas.1209408109.
59. Brügger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, et al. (2006) The HIV lipidome: a raft with an unusual composition. Proceedings of the National Academy of Sciences of the United States of America 103: 2641-2646 doi:10.1073/pnas.0511136103.
60. Chan R, Uchil PD, Jin J, Shui G, Ott DE, et al. (2008) Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. Journal of virology 82: 11228-11238 doi:10.1128/JVI.00981-08.
61. Jorgenson RL, Vogt VM, Johnson MC, (2009) Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. Journal of virology 83: 4060-4067 doi:10.1128/JVI.02425-08.
62. Muranyi W, Malkusch S, Müller B, Heilemann M, Kräusslich H-G, (2013) Super-Resolution Microscopy Reveals Specific Recruitment of HIV-1 Envelope Proteins to Viral Assembly Sites Dependent on the Envelope C-Terminal Tail. PLoS Pathogens 9: e1003198 doi:10.1371/journal.ppat.1003198.
63. Roy NH, Chan J, Lambele M, Thali M, (2013) Clustering and Mobility of HIV-1 Env at Viral Assembly Sites Predict its Propensity to Induce Cell-Cell Fusion. Journal of Virology 87: 7516-7525 doi:10.1128/JVI.00790-13.
64. Cannon PM, Matthews S, Clark N, Byles ED, Iourin O, et al. (1997) Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. Journal of virology 71: 3474-3483.
65. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D, (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. Journal of virology 72: 2855-2864.
66. Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, et al. (1994) A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS research and human retroviruses 10: 1651-1658.
67. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of virology 59: 284-291.
68. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, et al. (1988) In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. Journal of virology 62: 139-147.
69. Waheed AA, Ono A, Freed EO (2009) Methods for the study of HIV-1 assembly. In: Prasad VR, Kalpana G V., editors. HIV Protocols. Totowa, NJ: Humana Press, Vol. 485. pp.163-184. doi:10.1007/978-1-59745-170-3.
70. Pymol (2006). Available: http://www.pymol.org/.